Anixa Biosciences
Quarterly Financials
| Values in thousands | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -9 | 0 | ||
EBITDA | -2,436 | -2,994 | -3,386 | -3,154 |
EBIT | -3,003 | -3,163 | ||
Net Income | -2,258 | -2,790 | -3,184 | -2,883 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,511 | -1,503 | -2,904 | -927 |
Cash | 1,495 | 1,910 | 1,053 | 1,271 |
Basic Shares | 32,476 | 32,202 | 32,197 | 31,898 |
Annual Financials
| Values in thousands | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|
Revenue | $0 | $210 | $2,469,000 | $512 |
Gross Profit | -37 | 49 | 2,468,958 | 127 |
EBITDA | -12,661 | -10,965 | -13,729 | -13,081 |
EBIT | -12,698 | -11,011 | -13,771 | -13,141 |
Net Income | -12,554 | -9,811 | -13,491 | -12,946 |
Net Change In Cash | 0 | 210 | 2,469,000 | 512 |
Cost of Revenue | -16,768 | |||
Free Cash Flow | -7,335 | -6,209 | -6,492 | -4,936 |
Cash | 1,271 | 915 | 12,360 | 29,128 |
Basic Shares | 31,898 | 30,980 | 30,374 | 28,578 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-10-31 | $0 |
2025-07-31 | -$0.07 |
2025-04-30 | -$0.09 |
2025-01-31 | -$0.10 |
